Yustec Begins Its Public Listing Guidance Yustec Technology has officially initiated its public listing guidance as it prepares to enter the stock market.

The global IPO market remained broadly flat in the first half of 2025, with 539 deals raising US$61.4 billion.

When it comes to Asia’s equity capital markets, Morgan Stanley is a dominating force. Just take the numbers. In 2024, it was ...

This week’s Bulls N’ Bears ASX Runners of the Week is… Lumos Diagnostics, after the company signed an exclusive diagnostics ...

The amount raised via follow-on offerings reaches US$31.4 billion in the first half of 2025, outpacing all of 2024 Momentum ...

The U.S. FDA’s Oncologic Drugs Advisory Committee took up the matter of GSK plc’s relapsed/refractory multiple myeloma drug, Blenrep (belantamab mafodotin). A B-cell maturation antigen-directed ...

NTT DC REIT’s IPO was supposed to be a shot in the arm for Singapore’s flagging equity market, decried by analysts as “lackluster” due to its lack of growth stocks and tiny number of listings. NTT’s ...

Biel Crystal Manufactory Ltd., one of the world’s largest producers of glass covers for phones, is considering reviving its ...

Hong Kong's initial public offering market is gaining depth and dynamism and reinforcing its role as a premier global listing ...

Thirty-six biotechnology, pharmaceutical and medical device companies sought a capital raise on the Hong Kong Stock Exchange in the first half (H1) of 2025, a review by BioWorld found. Of those, 34 ...

First-day trading for Travel Food Services Limited, a joint venture with K Hospitality Corp., was weaker than both parties ...